Progress in endoscopic treatment of barrett′s esophagus

doi:10.3877/cma.j.issn.2095-7157.2021.03.008

Abstract

Abstract:

Barrett′s esophagus is a kind of precancerous lesion, which has the risk of developing into esophageal adenocarcinoma. In recent years, the morbidity rate of Barrett′s esophagus is gradually increasing. With the rapid development of digestive endoscopy, there are more new methods and new knowledge of endoscopic treatment of Barrett′s esophagus. This article reviews the latest progress in endoscopic treatment of Barrett′s esophagus.

Key words: Barrett′s esophagus, Endoscopic treatment, Progress

Shuai Zhang, Yingdi Liu, Enqiang Linghu. Progress in endoscopic treatment of barrett′s esophagus[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(03): 125-129.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2021.03.008

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2021/V08/I03/125

References 52

[1]	国家消化系统疾病临床医学研究中心，中华医学会消化内镜学分会，中国医师协会消化医师分会．中国巴雷特食管及其早期腺癌筛查与诊治共识(2017年，万宁)[J]. 中华消化内镜杂志，2017，34(9)：609-620.
[2]	van Soest EM,，Dieleman JP,，Siersema PD，et al. Increasing incidence of Barrett′s oesophagus in the general population[J]. Gut，2005，54(8)：1062-1066.
[3]	Shiota S,，Singh S,，Anshasi A，et al. Prevalence of Barrett′s Esophagus in Asian Countries：A Systematic Review and Meta-analysis[J]. Clin Gastroenterol Hepatol，2015，13(11)：1907-1918.
[4]	Naini BV,，Souza RF,，Odze RD. Barrett′s Esophagus：A Comprehensive and Contemporary Review for Pathologists[J]. Am J Surg Pathol，2016，40(5)：e45-66.
[5]	Schlemper RJ,，Riddell RH,，Kato Y，et al. The Vienna classification of gastrointestinal epithelial neoplasia[J]. Gut，2000，47(2)：251-255.
[6]	Sikkema M,，Looman CW,，Steyerberg EW，et al. Predictors for neoplastic progression in patients with Barrett′s Esophagus：a prospective cohort study[J]. Am J Gastroenterol，2011，106(7): 1231-1238.
[7]	Wani S,，Qumseya B,，Sultan S，et al. Endoscopic eradication therapy for patients with Barrett′s esophagus-associated dysplasia and intramucosal cancer[J]. Gastrointest Endosc，2018，87(4)：907-931.e9.
[8]	Shaheen NJ,，Falk GW,，Iyer PG，et al. ACG Clinical Guideline: Diagnosis and Management of Barrett′s Esophagus[J]．Am J Gastroenterol，2016，111(1)：30-50; quiz 51.
[9]	Desai M,，Saligram S,，Gupta N，et al. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett′s esophagus-related neoplasia：a？systematic review and pooled analysis[J]. Gastrointest Endosc，2017，85(3)：482-495.e4.
[10]	Chadwick G,，Groene O,，Markar SR，et al. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett′s esophagus：a critical assessment of histologic outcomes and adverse events[J]. Gastrointest Endosc，2014，79(5)：718-731.e3.
[11]	Pimentel-Nunes P,，Dinis-Ribeiro M,，Ponchon T, et al. Endoscopic submucosal dissection：European Society of Gastrointestinal Endoscopy (ESGE) Guideline[J]. Endoscopy，2015，47(9): 829-854.
[12]	Martelli MG,，Duckworth LV,，Draganov PV.Endoscopic Submucosal Dissection Is Superior to Endoscopic Mucosal Resection for Histologic Evaluation of Barrett′s Esophagus and Barrett′s-Related Neoplasia[J]. Am J Gastroenterol，2016，111(6)：902-903.
[13]	Swager AF,，Boerwinkel DF,，de Bruin DM，et al. Detection of buried Barrett′s glands after radiofrequency ablation with volumetric laser endomicroscopy[J]. Gastrointest Endosc，2016，83(1)：80-88.
[14]	Alvarez Herrero L,，Pouw RE,，van Vilsteren FG，et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett′s esophagus[J]. Endoscopy，2011，43(3)：177-183.
[15]	Pouw RE,，Beyna T,，Belghazi K，et al. A prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett′s esophagus[J]. Gastrointest Endosc，2018，88(4)：647-654.
[16]	Peters FP,，Kara MA,，Curvers WL，et al. Multiband mucosectomy for endoscopic resection of Barrett′s esophagus：feasibility study with matched historical controls[J]. Eur J Gastroenterol Hepatol, 2007，19(4)：311-315.
[17]	龙丹，王富华，曾锦荣，等. 透明帽法黏膜切除术与多环套扎黏膜切除术治疗早期食管癌及癌前病变的临床效果[J]. 慢性病学杂志，2020，21(5)：753-754; 757.
[18]	Fujiya M,，Tanaka K,，Dokoshi T，et al. Efficacy and adverse events of EMR and endoscopic submucosal dissection for the treatment of colon neoplasms：a meta-analysis of studies comparing EMR and endoscopic submucosal dissection[J]. Gastrointest Endosc，2015, 81(3)：583-595.
[19]	Yang D,，Zou F,，Xiong S，et al. Endoscopic submucosal dissection for early Barrett′s neoplasia：a meta-analysis[J]. Gastrointest Endosc，2018，87(6)：1383-1393.
[20]	Terheggen G,，Horn EM,，Vieth M，et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett′s neoplasia[J]. Gut，2017，66(5)：783-793.
[21]	Deprez PH,，Piessevaux H,，Aouattah T，et al. 587c：ESD in Barrett′s Esophagus High Grade Dysplasia and Mucosal Cancer：Prospective Comparison With CAP Mucosectomy[J]. Gastrointest Endosc，2010，71(5).
[22]	Chedgy F,，Subramaniam S,，Kandiah K，et al. Tu1155 EMR vs ESD for Barrett′s Neoplasia：Time to shift the paradigm？[J]. Gastrointest Endosc，2016，83(5)：AB556-AB557.
[23]	Haidry R,，Lovat L,，Sharma P. Radiofrequency ablation for Barrett′s dysplasia：past，present and the future？[J]. Curr Gastroenterol Rep, 2015，17(3)：1-6.
[24]	Phoa KN,，van Vilsteren FG,，Weusten BL，et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia：a randomized clinical trial[J]. Jama，2014，311(12)：1209-1217.
[25]	Pouw RE,，Klaver E,，Phoa KN，et al. Radiofrequency ablation for low-grade dysplasia in Barrett′s esophagus：long-term outcome of a randomized trial[J]. Gastrointest Endosc，2020，92(3)：569-574.
[26]	Qumseya BJ,，Wani S,，Gendy S，et al. Disease progression in Barrett′s low-grade dysplasia with radiofrequency ablation compared with surveillance：systematic review and meta-analysis[J]．Am J Gastroenterol，2017，112(6)：849-865.
[27]	Rosmolen WD,，Phoa N,，Nieuwkerk PT，et al. Impact of ablation of Barrett′s esophagus with low-grade dysplasia on patients′ illness perception and quality of life：a multicenter randomized trial[J]. Gastrointest Endosc，2019，90(2)：215-221.
[28]	Sharma P,，Shaheen NJ,，Katzka D，et al. AGA Clinical Practice Update on Endoscopic Treatment of Barrett′s Esophagus With Dysplasia and/or Early Cancer Expert Review[J]. Gastroenterology，2020，158(3)：760-769.
[29]	Phoa KN,，Pouw RE,，van Vilsteren FGI，et al. Remission of Barrett′s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection：a Netherlands cohort study[J]. Gastroenterology，2013，145(1)：96-104.
[30]	Krajciova J,，Janicko M,，Falt P，et al. Radiofrequency Ablation in Patients with Barrett′s Esophagus-related Neoplasia - Long-Term Outcomes in the Czech National Database[J]. J Gastrointestin Liver Dis，2019，28(1)：149-155.
[31]	Guthikonda A,，Cotton CC,，Madanick RD，et al. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett′s Esophagus With Radiofrequency Ablation[J]. Am J Gastroenterol，2017，112(1)：87-94.
[32]	Gosain S,，Mercer K,，Twaddell WS，et al. Liquid nitrogen spray cryotherapy in Barrett′s esophagus with high-grade dysplasia: long-term results[J]. Gastrointest Endosc，2013，78(2)：260-265.
[33]	Gage AA,，Baust J. Mechanisms of tissue injury in cryosurgery[J]. Cryobiology，1998，37(3)：171-186.
[34]	Canto MI. Cryotherapy for Barrett′s Esophagus[J]. Gastrointest Endosc Clin N Am，2017，27(3)：503-513.
[35]	van Munster SN,，Overwater A,，Haidry R，et al. Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett′s esophagus: impact on treatment response and postprocedural pain[J]. Gastrointest Endosc，2018，88(5)：795-803.e2.
[36]	Dam AN,，Klapman J. A narrative review of Barrett′s esophagus in 2020, molecular and clinical update[J]. Ann Transl Med，2020，8(17)：1107-1107.
[37]	Hamade N,，Desai M,，Thoguluva Chandrasekar V，et al. Efficacy of cryotherapy as first line therapy in patients with Barrett′s neoplasia：a systematic review and pooled analysis[J]. Dis Esophagus，2019，32(11)：doz040.
[38]	Mohan BP,，Krishnamoorthi R,，Ponnada S，et al. Liquid Nitrogen Spray Cryotherapy in Treatment of Barrett′s Esophagus，where do we stand? A Systematic Review and Meta-Analysis[J]．Dis Esophagus，2019，32(6)：doy130.
[39]	Canto MI,，Shin EJ,，Khashab MA，et al. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett′s esophagus[J]. Endoscopy，2015，47(7)：582-591.
[40]	Canto MI,，Trindade AJ,，Abrams J，et al. Multifocal Cryoballoon Ablation for Eradication of Barrett′s Esophagus-Related Neoplasia：A Prospective Multicenter Clinical Trial[J]. Am J Gastroenterol，2020，115(11)：1879-1890.
[41]	Wronska E,，Polkowski M,，Orlowska J，et al.Argon plasma coagulation for Barrett′s esophagus with low-grade dysplasia：a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose[J]. Endoscopy，2021，53(2)：123-132.
[42]	Manner H,，Rabenstein T,，Pech O，et al. Ablation of residual Barrett′s epithelium after endoscopic resection：a randomized long-term follow-up study of argon plasma coagulation vs. surveillance(APE study)[J]. Endoscopy，2014，46(1)：6-12.
[43]	Peerally MF,，Bhandari P,，Ragunath K，et al. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett′s esophagus：a randomized pilot study(BRIDE)[J]. Gastrointest Endosc，2019，89(4)：680-689.
[44]	Manner H,，May A,，Kouti I，et al. Efficacy and safety of Hybrid-APC for the ablation of Barrett′s esophagus[J]．Surg Endosc，2016，30(4)：1364-1370.
[45]	Kashin SV,，Kuvaev R,，Nadezhin AS，et al. Mo2016 The New Hybrid Argon Plasma Coagulation(Hybrid APC) for Endoscopic Ablation of Barrett′s Esophagus(BE)：the Results of the Pilot Trial[J]. Gastrointest Endosc，2016，83(5)：AB495.
[46]	Qumseya BJ,，David W,，Wolfsen HC. Photodynamic Therapy for Barrett′s Esophagus and Esophageal Carcinoma[J]. Clin Endosc, 2013，46(1)：30-37.
[47]	Overholt BF,，Lightdale CJ,，Wang KK，et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett′s esophagus：international，partially blinded，randomized phase III trial[J]. Gastrointest Endosc，2005，62(4)：488-498.
[48]	Grade AJ,，Shah IA,，Medlin SM，et al. The efficacy and safety of argon plasma coagulation therapy in Barrett′s esophagus[J]. Gastrointest Endosc，1999，50(1)：18-22.
[49]	Prasad GA,，Wang KK,，Buttar NS，et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett′s esophagus[J]. Gastroenterology，2007，132(4)：1226-1233.
[50]	Van Laethem JL,，Peny MO,，Salmon I，et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett′s oesophagus[J]. Gut，2000，46(4)：574-577.
[51]	Gray NA,，Odze RD,，Spechler SJ.Buried metaplasia after endoscopic ablation of Barrett′s esophagus：a systematic review[J]. Am J Gastroenterol，2011，106(11)：1899-1908; quiz 1909.
[52]	Overholt BF,，Wang KK,，Burdick JS，et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett′s high-grade dysplasia[J]. Gastrointest Endosc，2007，66(3)：460-468.

Please choose a citation manager

Content to export